the patient impact of a reliable information tool
charlene newland was advised not to turn to the internet for answers after her stage 2 breast cancer diagnosis at 33 years old. however, at the time she felt that she was left with little choice.
“i was in so much denial after receiving my diagnosis, and no one in my circle or community was having these conversations,” explained charlene. “in between doctor appointments, i turned to dr. google. as you can imagine, it sent me down a rabbit hole of unreliable information that only planted further doubt and uncertainty.”
with progress connect, breast cancer patients like charlene will have an accessible and reliable resource in addition to their oncology team to learn more about their type of breast cancer and treatment options.
on the heals of the progress connect launch, bcc also announced new funding for two new research teams:
$200,000 in screening and detection research grants announced
bcc in collaboration with astrazeneca is proud to announce the recipients of new funding dedicated to research in breast cancer screening and detection. this granting partnership includes additional in-kind support from illumina canada and sought to identify two canadian research teams committed to advancing breast cancer screening or detection through the integration of precision diagnostics and ai technology.